Purchase Order W81K0021P0207
- Not listed
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 (VA - VHA) awarded a $3.5 million Firm Fixed Price definitive contract to Austin Nuclear Pharmacy Services LLC to provide radiopharmaceuticals. The place of performance will be in Temple, Texas and the contract period runs from August 9, 2023 through August 8, 2028. No subcontractors were identified. Radiopharmaceuticals are radioactive pharmaceuticals used in medical imaging and treatment...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, valued at $202,467.88, is for the supply of radiopharmaceuticals, including specialized medical isotopes such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. This...
- This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the provision of radioactive imaging agents. The contract has a ceiling value of $109,429.75 and a performance period through July 15, 2025. It is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type, awarded by the Defense Health Agency (DHA), a defense agency. The contract supports the supply of a wide range of radiopharmaceutical products, including technetium-99m,...
- This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA) to Panhandle Nuclear RX, LTD., a for-profit partnership or limited liability partnership based in Amarillo, Texas. The contract is for the provision of radiopharmaceuticals, with a ceiling value of $38,009.00 and a period of performance through April 30, 2025. This contract is not set aside and is part of a larger Indefinite Delivery...
- This $955,499.55 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of radiopharmaceuticals, including specialized medical isotopes such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has an...
- This is a firm-fixed-price delivery order contract awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., to provide radiopharmaceuticals to the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 21. The contract has a potential value of $406,942.11 and covers the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well...
- This federal contract award, valued at $1,020,000.00, was issued by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of various radiopharmaceuticals, which are critical medical isotopes used in nuclear medicine and diagnostic imaging procedures. The contract is structured as a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type. It has an ultimate completion date of September 30, 2025....
- This is a federal delivery order contract awarded by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer...
- This is a $46,954.84 firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer...
- This federal contract award was issued by the Defense Health Agency to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $3,000.00 Firm Fixed Price contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has an ultimate completion date of September...
This firm-fixed-price contract was awarded by the Defense Health Agency to Austin Nuclear Pharmacy Services LLC for the provision of radiopharmaceuticals to the Carl R. Darnall Army Medical Center Nuclear Medicine Department located on Fort Hood, Texas. The contract has a ceiling value of $373,371.45 and runs from October 1, 2021 through September 30, 2025. The radiopharmaceuticals required include 111 In DTPA, 67 Gallium Citrate, 99m Tc04 MAG-3, 201 Thallous Chloride, 99m Tc Sestamibi, 99m Tc Bicisate, 123 Iodine, and 131 Iodine Capsules. There was no set-aside designation for this procurement, which was based on a sources sought notice issued in March 2021. The contract was awarded under NAICS code 325412 - Pharmaceutical Preparation Manufacturing.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Radiopharmaceuticals | W81K0021Q0103 | Department of the Army Medical Command | Pre-Solicitation 2/4 | 5/26/21, 5:44 PM | |
Radiopharmaceuticals | 0011617324 | Department of the Army Medical Command | Pre-Solicitation 1/4 | 3/10/21, 12:18 PM | |
Radiopharmaceuticals | W81K0021Q0103 | Department of the Army Medical Command | Solicitation 3/4 | 6/8/21, 11:26 AM | |
Radiopharmaceuticals | W81K0021P0207 | Department of the Army Medical Command | Award Notice 4/4 | 7/29/21, 3:34 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00020 | Funding Only Action | ($158k) | 5/5/25 | |
| P00019 | Funding Only Action | ($30k) | 2/25/25 | |
| P00018 | Funding Only Action | $271.4k | 10/30/24 | |
| P00017 | Funding Only Action | ($160k) | 5/7/24 | |
| P00016 | Funding Only Action | ($103k) | 12/27/23 |